Fotemustine in recurrent or progressive glioblastoma multiforme (GBM)

被引：0
|
作者：
Savio, G. [1 ]
Pepe, A. [1 ]
Laudani, A. [1 ]
Leonardi, V [1 ]
Usset, A. [1 ]
Rondello, G. [1 ]
Arcuri, C. [1 ]
Palmisano, V [1 ]
Alu', M. [1 ]
Macaluso, M. [1 ]
Agostara, B. [1 ]
机构：
[1] ARNAS Civic, Oncol Hosp, Dept Oncol, Palermo, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [31] Promising survival with Dacarbazine and Fotemustine in newly diagnosed glioblastoma multiforme
    Fazeny-Doerner, Barbara
    Veitl, Mario
    Wenzel, Catharina
    Roessler, Karl
    Dieckmann, Karin
    Hainfellner, Johannes
    Marosi, Christine
    ANNALS OF ONCOLOGY, 2004, 15 : 208 - 208
  • [32] Phase I study of gefitinib and rapamycin in patients with recurrent or progressive glioblastoma (Gbm).
    Das, A
    Badruddoja, M
    Tryciecky, D
    Yu, J
    Black, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 132S - 132S
  • [33] IPILIMUMAB FOR RECURRENT GLIOBLASTOMA (GBM)
    Schaff, Lauren R.
    Lassman, Andrew B.
    Goldlust, Samuel A.
    Cloughesy, Timothy
    Singer, Samuel
    Schwartz, Gary K.
    Iwamoto, Fabio M.
    NEURO-ONCOLOGY, 2014, 16
  • [34] Fotemustine as rescue therapy in recurrent or progressive glioblastoma after first-line temozolomide chemotherapy
    Lolli, Ivan
    Divella, Rosa
    Silvano, Giovanni
    Finamore, Simona
    Ercolino, Letizia
    Ronco, Michele
    Ciappetta, Pasqualino
    Troccoli, Giuseppe
    ANNALS OF ONCOLOGY, 2007, 18 : 64 - 64
  • [35] Phase I trial of imatinib mesylate, hydroxyurea and vatalanib for patients with recurrent glioblastoma multiforme (GBM)
    Sathornsumetee, S.
    Rich, J. N.
    Vredenburgh, J. J.
    Desjardins, A.
    Quinn, J. A.
    Gururangan, S.
    Egorin, M. J.
    Salvado, A. J.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Re-Irradiation for Recurrent Glioblastoma Multiforme (GBM) : Systematic Review and Meta-Analysis
    Vellayappan, B.
    Kazmi, F.
    Lim, K. H. C.
    Yeo, T. T.
    Wong, A.
    Soon, Y. Y.
    Koh, W. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E114 - E114
  • [37] A Prospective 4I Radiotherapy Clinical Trial in Recurrent Glioblastoma Multiforme (GBM) Patients
    Yu, V.
    Landers, A.
    Woods, K.
    Nguyen, D.
    Cao, M.
    Chin, R.
    Kaprealian, T.
    Sheng, K.
    MEDICAL PHYSICS, 2017, 44 (06) : 2999 - 3000
  • [38] BEVACIZUMAB (BEV) ALONE OR IN COMBINATION WITH CHEMOTHERAPY IN RECURRENT GLIOBLASTOMA MULTIFORME (GBM): A REAL WORLD EXPERIENCE
    Chalchal, H. I.
    Zhu, T.
    Woitas, C.
    Ahmed, S.
    Souied, O.
    Iqbal, M.
    Ahmed, O.
    Sami, A.
    Dueck, D.
    Magdi, A.
    NEURO-ONCOLOGY, 2021, 23 : 52 - 52
  • [39] Safety and efficacy of fotemustine in recurrent or progressive gliomas
    Trevisan, E.
    Laguzzi, E.
    Ruda, R.
    Guarneri, D.
    Soffietti, R.
    JOURNAL OF NEUROLOGY, 2008, 255 : 19 - 19
  • [40] Reoperation for Recurrent Glioblastoma Multiforme
    Robin, Adam M.
    Lee, Ian
    Kalkanis, Steven N.
    NEUROSURGERY CLINICS OF NORTH AMERICA, 2017, 28 (03) : 407 - +
12345